ACKR3 and rheumatoid arthritis: Besides, our findings provide a potential risk for the combination of CCX733 and MSCs in treatment of RA because inhibition of CXCR7 in MSCs can reduce their osteogenic or chondrogenic differentiation and immunosuppressive properties.